Iran has received more than 700,000 doses of AstraZeneca’s coronavirus vaccine as part of the World Health Organization’s global COVAX drug distribution program.
The shipment of the vaccine was sent to severely affected Iran by the coronavirus on Sunday, April 4.
“About 790,000 doses of the vaccine have been imported into the country so far, according to Alirez Raeisi, spokesman for the National Coronavirus Headquarters,” said Qianush Jahanpour, head of the Iranian Ministry of Health’s public relations department.
He noted that the Islamic Republic purchased 16.8 million doses of vaccine through the COVAX program.
“They were supposed to deliver 4.2 million doses since March 21, but about 780,000 have been delivered. About 250,000 people in the country have now been vaccinated, and about 56,000 more have received a second dose,” he added.
Notably, in mid-February, Iran began a vaccination campaign with the Russian Sputnik V vaccine. The country also produces its own Coviran Barekat and Razi Cov Pars. A third self-produced vaccine, called Fahra, is undergoing clinical trials.